Home

CATHY FRIEDMAN

CIK 1411874 · last filed 2026-06-12

CATHY FRIEDMAN is a corporate insider who has filed 50 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for LYEL, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$398.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.97M

Companies

7

Total Filings

50

Lifetime Open-Market Net

$398.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LYEL Director 5,000 $13.55 $67.8K $300.0K 8 2026-06-12
SEER Director 173,574 $2.03 $352.4K $0 4 2023-06-16
Radius Health, Inc. (RDUS) Delisted Director 0 $30.00 $0 $0 12 2022-08-15
INVA Director 73,805 $20.96 $1.55M $0 2 2017-04-24
XENOPORT INC (XNPT) Delisted Director 0 — — $98.3K 11 2016-07-06
ReShape Weightloss Inc. (ETRM) Delisted Director 13,800 — — $0 8 2015-05-08
Innoviva, Inc. (THRX) Delisted Director 35,620 $4.06 $144.6K $0 2 2015-04-27

Recent Filings

50 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 LYEL Grant (A) — $0 EDGAR
2025-05-19 LYEL Grant (A) — $0 EDGAR
2024-06-17 LYEL Grant (A) — $0 EDGAR
2023-09-08 LYEL Grant (A) — $0 EDGAR
2023-06-20 LYEL Grant (A) — $0 EDGAR
2023-06-16 SEER Grant (A) +23,443 $0 EDGAR
2022-08-15 Radius Health, Inc. (RDUS) Delisted Disp (D) −26,800 -$268.0K EDGAR
2022-06-17 SEER Grant (A) +9,945 $0 EDGAR
2022-06-10 LYEL Grant (A) — $0 EDGAR
2022-01-25 Radius Health, Inc. (RDUS) Delisted Grant (A) +5,500 $0 EDGAR
Showing 1–10 of 50
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.